Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 

Accueil Zonebourse  >  Actions  >  Euronext Paris  >  NicOx SA    NCOX   FR0000074130

NICOX SA (NCOX)

Mes dernières consult.
Top consultations
1766
SynthèseGraphiquesActualitésAnalysesAgendaSociétéFinancesConsensusRévisionsFondsCommunauté 
Métier
Logo NicOx SA
Developes and manufactures biopharmaceuticals

Nicox SA is an international commercial-stage company focused on the ophthalmic market.

It seeks and evaluate commercial and late-stage ophthalmic products.

The company was founded by Piero Del Soldato, Michele Garufi and Elizabeth Marie Robinson on February 15, 1996 and is headquartered in Sophia-Antipolis, France.
Dirigeants
Nom AgeDepuisTitre
Michele Garufi611996Chairman & Chief Executive Officer
Philippe Masquida542012Executive Vice President & MD-European Operations
Sandrine Gestin481999Finance Director
Michael Bergamini, PhD-2014Chief Scientific Officer & Executive VP
Jean-François Labbé, MBA662010Director
Birgit Stattin Norinder682011Director
Adrienne L. Graves, PhD612014Director
Luzi Andreas von Bidder632014Director
Lester J. Kaplan, PhD652014Director
Gavin M. Spencer, PhD452005Executive Vice President-Corporate Development
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 22 870 000 22 643 897 99.0% 0 0.0% 99.0%
Actionnaires
Nom Actions%
Bpifrance Participations SA /PRIVATE EQUITY/ 790 514 3,45%
New Enterprise Associates LLC 283 094 1,24%
Michele Garufi 181 051 0,79%
OP Asset Management Ltd. 125 000 0,55%
Dimensional Fund Advisors LP 98 923 0,43%
Talence Gestion SAS 80 000 0,35%
Elizabeth Marie Robinson, PhD 74 060 0,32%
Lester J. Kaplan, PhD 69 131 0,30%
Nicox SA 50 903 0,22%
Meeschaert Asset Management SA 16 000 0,070%
Participations
Nom Actions%Valorisation
Nicox (COX) 50 9030,22%678 608 USD
Secteur
Santé
Recherche pharmaceutique et médicale
 Produits pharmaceutiques
  Produits pharmaceutiques
   Pharmacies spécialisées et de pointe
Publicité
Secteur Pharmacies spécialisées et de pointe
Var. 1janvCapitalisation (M$)
NICOX SA-22.33%282
ABBVIE INC8.58%104 029
BIOGEN INC-6.20%62 964
MERCK KGAA8.24%13 798
KYOWA HAKKO KIRIN CO L..0.58%10 637
JAZZ PHARMACEUTICALS P..0.55%8 549
MALLINCKRODT PLC-10.48%7 304
ZHANGZHOU PIENTZEHUANG..6.89%4 346
YUHAN CORPORATION--.--%2 950
INDIVIOR PLC45.21%2 559
MAYNE PHARMA GROUP LTD36.88%2 164
THERAPEUTICSMD INC-24.98%1 494
NICHI-IKO PHARMACEUTIC..-23.32%1 320
ADVANCED ACCELERATOR A..--.--%1 218
LG LIFE SCIENCES, LTD--.--%1 104
SUPERNUS PHARMACEUTICA..59.97%1 063
REPLIGEN CORPORATION-4.60%908
DONG-A ST CO LTD--.--%899
RECIPHARM PUBL AB15.57%744
EAGLE PHARMACEUTICALS ..-47.96%721
AB SCIENCE16.11%565
Secteur Pharmacies spécialisées et de pointe
NicOx SA : Connexions
The Clinical Research Institute of the Foundation
KeepYourSight Foundation
The Association for Research in Vision & Ophthalmology
Aciex Therapeutics, Inc.
Delife SRL
Wingfirm Pharma AB
Himalayan Cataract Project
Partners For Utvecklingsinvesteringar Inom Life Sciences AB
Navigation Dynamics AB
Keck Graduate Institute of Applied Life Sciences
Wntresearch AB
Encore Vision, Inc.
American Glaucoma Society
Pan-American Ophthalmological Foundation
Envisia Therapeutics, Inc.
Relivia SRL
American Academy of Ophthalmology, Inc.
Women in Ophthalmology
Ferring Holding SA
American Academy of Ophthalmology Foundation
Ferring International Center SA
The American Society of Cataract & Refractive Surgery
Neurotech Pharmaceuticals, Inc. (United States)
Glaucoma Research Foundation
Medinox, Inc.
Aerpio Therapeutics, Inc.
FFB Clinical Research Institute
Coordonnées société
Nicox SA
Drakkar 2 - Bât D
2405 route des Dolines
Sophia-Antipolis, Provence-Alpes-Cote-dAzur 06560

Phone : +33.4.97.24.53.00
Fax : +33.4.97.24.53.99
Web : www.nicox.com
© 2016 People , Fundamentals and Ownership